Postpartum Depression (PPD) Market Insights, Epidemiology and Market Forecast 2030

1. Postpartum Depression Market Size, Share, Industry Analysis and Forecast, 2030 DelveInsight’s ‘Postpartum Depression (PPD) - Market Insights, Epidemiology and Market Forecast - 2030’ report delivers an in-depth understanding of the Postpartum Depression (PPD), historical and forecasted epidemiology as well as the Postpartum Depression (PPD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Postpartum Depression (PPD) Overview Postpartum depression (PPD) is the most common non-psychotic, complication of childbearing affecting approximately 10–15% of women and as such, represents a considerable public health problem affecting women and their families. The postnatal period is well established as an increased time of risk for the development of serious mood disorders. There are three common forms of postpartum affective illness: the blues (baby blues, maternity blues), postpartum (or postnatal) depression, and puerperal (postpartum or postnatal) psychosis each of which differs in its prevalence, clinical presentation, and management. Postpartum depression usually begins within 1–12 months after delivery. In some women, post-partum blues simply continue and become more severe. In others, a period of wellbeing after delivery is followed by a gradual onset of depression. The patterns of symptoms in women with postpartum depression are similar to those in women who have depression unrelated to childbirth. Several factors can lead to

2. postpartum depression. Women with a history of depression and other mental health conditions face a higher risk of PPD. Postpartum Depression (PPD) Diagnosis Women who are at risk for postpartum depression should be identified as soon as possible during pregnancy so that appropriate follow-up and care can be initiated. Risk factors for postpartum depression include depression, anxiety, stressful life events during pregnancy or the early puerperium, low levels of social support, and a personal or family history of depression. Women with a history of postpartum depression are also at increased risk of recurrence. Postpartum Depression (PPD) Treatment Antidepressant medications, cognitive-behavioral therapy (CBT), and interpersonal therapy are effective in the treatment of PPD. Other treatments, which may be useful include psychodynamic therapy, light therapy, exercise, and yoga, but the current research evidence about the efficacy of such treatment regimens is more preliminary. Postpartum Depression (PPD) Epidemiology In the 7MM, the total diagnosed prevalent cases of PPD in 2017 were 1,134,800 out of which the highest diagnosed prevalent cases of this disease were seen in the United States, which were 609,900, which is expected to increase during forecast period (2020–2030). As per the estimates, in Japan the diagnosed prevalence of PPD was found to be the second highest after the US with 116,280 in 2017. Postpartum Depression (PPD) Market Outlook The United States accounts for the largest market size of Postpartum Depression (PPD), in comparison to EU5 (the United Kingdom, Germany, Italy, France, and Spain) and Japan. The market size of Postpartum Depression (PPD) in the seven major markets is USD 138.75 Million in 2017 for the study period (2017–2030). View full report: https://www.delveinsight.com/report- store/postpartum-depression-market Request for sample pages: https://www.delveinsight.com/sample- request/postpartum-depression-market